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The allosteric and torpedo models have been used for 30 yr to explain how transcription terminates on protein-
coding genes. The former invokes termination via conformational changes in the transcription complex and the
latter proposes that degradation of the downstream product of poly(A) signal (PAS) processing is important. Here, we
describe a single mechanism incorporating features of both models. We show that termination is completely abol-
ished by rapid elimination of CPSF73, which causes very extensive transcriptional readthrough genome-wide. This
is because CPSF73 functions upstream of modifications to the elongation complex and provides an entry site for the
XRN2 torpedo. Rapid depletion of XRN2 enriches these events that we show are underpinned by protein phos-
phatase 1 (PP1) activity, the inhibition of which extends readthrough in the absence of XRN2. Our results suggest a
combined allosteric/torpedo mechanism, in which PP1-dependent slowing down of polymerases over termination
regions facilitates their pursuit/capture by XRN2 following PAS processing.
[Keywords: XRN2; transcriptional termination; CPSF73; polyadenylation signal; RNA polymerase II; PP1;
antisense oligo]
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Termination by RNA polymerase II (Pol II) completes the
transcriptioncycle. It servesto recyclePol II fornewrounds
of initiation and prevents interference with the transcrip-
tion of neighboring genes. On protein-coding genes, tran-
scriptional termination is mechanistically connected
with 3′ end formation, which involves cleavage and polya-
denylation (CPA) (Proudfoot 2011). For CPA, a multipro-
tein complex is recruited to the polyadenylation signal
(PAS), which consists of a hexamer (usually AAUAAA)
and a downstream GU (or U)-rich sequence. The 73-kDa
component of cleavage and polyadenylation specificity
factor (CPSF73) is the endonuclease that cleaves between
these two sequences (Mandel et al. 2006). A poly(A) tail is
added to the stable upstream cleavage product and the
downstream RNA is rapidly degraded. Mutation of the
PAS hexamer prevents transcriptional termination—a re-
sult that led to two models to explain termination that
have been debated ever since (Connelly and Manley
1988; Proudfoot 1989).
The allosteric (or antiterminator) model proposes that
transcription of the PAS induces a change in the elonga-
tion complex that renders it prone to termination (Logan
et al. 1987). Thismight involve the exchange of associated
factors or modification of proteins including Pol II as
shown by chromatin immunoprecipitation (ChIP) experi-
ments (Ahn et al. 2004; Kim et al. 2004a). There are also
examples of antitermination factors in budding yeast
(PC4) and humans (SCAF4 and SCAF8) (Calvo andManley
2001; Gregersen et al. 2019). Conversely, the 3′ end pro-
cessing factor, PCF11, can release Pol II fromDNA in vitro
(Zhang and Gilmour 2006). Allostery may constitute pro-
tein modification(s) with phosphorylation-based switches
underpinning the 3′ end transition in budding and fission
yeast (Schreieck et al. 2014; Kecman et al. 2018; Parua
et al. 2018). Specifically dephosphorylation of the Pol II
C-terminal domain (CTD) and the SPT5 elongation factor
occur after the PAS during an elongation to termination
transition. Finally, Pol II conformational changes can re-
sult from PAS transcription in purified systems (Zhang
et al. 2015).
The torpedo model proposes that the Pol II-associated
product of PAS cleavage is degraded by a 5′ → 3′ exonucle-
ase leading to termination (Connelly and Manley 1988;
Proudfoot 1989). Evidence for this mechanism was first
provided in budding yeast and human cells where muta-
tion or depletion of their respective nuclear 5′ →3′ exonu-
cleases, Rat1 and XRN2, inhibits termination (Kim et al.
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2004b; West et al. 2004). Subsequent studies confirmed
the generality of these findings in both organisms (Fong
et al. 2015; Baejen et al. 2017; Eaton et al. 2018). An impor-
tant distinction between the torpedo and allosteric mech-
anisms is that, in principle, only the former requires PAS
cleavage. However, an inactivating point mutation in
CPSF73 does not support termination arguing that PAS
cleavage cannot readily be bypassed in cells (Eaton et al.
2018).
Given the substantial evidence for both models, it is
likely that termination actually employs aspects of each.
One possibility is that some genes use an allosteric pro-
cess with others using XRN2. This might be the case in
C. elegans, where XRN2 depletion causes termination de-
fects on only a subset of genes (Miki et al. 2017). Another
scenario is that allosteric and torpedo processes contrib-
ute to a common mode of termination as has been pro-
posed in budding yeast where PCF11 and Rat1 are each
required for the others recruitment to genes (Luo et al.
2006). Although human PCF11 is recruited to genes irre-
spective of XRN2 (Eaton et al. 2018), some PAS-dependent
processes could aid XRN2 function. For instance, Pol II
pausing downstream from a PAS could facilitate its pur-
suit by XRN2 especially since pausing enhances termina-
tion on reporter plasmids (Gromak et al. 2006).
We investigated the transcriptional termination mech-
anism in human cells using modified cell lines that allow
more rapid depletion of CPSF73 or XRN2 thanmore com-
monly used systems. CPSF73 depleted in this manner
causes profound readthrough suggesting that its function
is essential for termination and that there are no signifi-
cant fail-safe mechanisms in its absence. CPSF73 is re-
quired to slow down Pol II beyond the PAS and for
phosphorylation of its CTD on threonine 4 (Thr4p). These
slowed-down polymerases pile up beyond the PAS, and
their presence, is enriched by rapid depletion of XRN2.
Strikingly, longer readthrough can be induced in the ab-
sence of XRN2 by inhibiting or depleting protein phospha-
tase 1 (PP1), identifying a mechanistic basis for the pause.
We propose that allosteric events facilitate the pursuit of
Pol II and its termination by XRN2 constituting a unified
allosteric/torpedo mechanism for transcriptional termi-
nation on human protein-coding genes.
Results
CPSF73-associated functions are critical for termination
on protein-coding genes
We previously found that rapid elimination of XRN2, via
an auxin-inducible degron (AID), causes a general termi-
nation defect on protein-coding genes (Eaton et al. 2018).
In the same study, CPSF73 elimination via an E. coli-
derived DHFR degron caused more extended readthrough
of selected genes, implying a comparatively more impor-
tant role for its activities in termination. The DHFR
degron requires ∼10 h for depletion, whereas XRN2-AID
could be depleted faster, so we tagged CPSF73 with an
AID to better-compare CPSF73 and XRN2 functions
(Fig.1A; Natsume et al. 2016). AID depletion requires
the plant TIR1 protein, which was integrated into
HCT116 cells (chosen for their diploid karyotype) to allow
its doxycycline (dox)-dependent induction. The Western
blot in Figure 1B confirms homozygous tagging of
CPSF73 and that full depletion depends on both dox and
auxin. As well as using the same tag, depletion can be
achieved in 3 h, providing a more direct comparison to
the XRN2-AID system. Note that dox treatment alone in-
ducesmild CPSF73 depletion, whichmay bewhywewere
previously unable to combine CPSF73-AIDwith constitu-
tive TIR1 expression (Eaton et al. 2018).
To broadly assess the impact of rapid CPSF73 depletion
on transcription,weperformedRNA-sequencing inmock-
treated CPSF73-AID cells or the same cells treated with
dox and then auxin. Chromatin-associated RNA was se-
quenced because it is highly enriched in the nascent tran-
scripts thatwewished to study. Rapid depletion ofCPSF73
caused very obvious and widespread transcriptional read-
through as shown by the chromosome snapshot in Figure
1C. In this 5-Mb view, boundaries of gene transcription
are easily observed, but become blurred by profound
readthrough following CPSF73 elimination. Zoomed-in
tracks of example protein-coding genes (MAP2K4 and
YTHDC2) further detail this effect where readthrough is
forhundreds ofkilobases (Fig. 1D).Ametageneplotof tran-
scription across all expressed genes, separated by at least
100 kb, showed that long readthrough is general when
CPSF73 is depleted (Fig. 1E). This metagene also shows
that CPSF73 loss causes a global reduction in gene body
signal, suggesting that its presence positively impacts on
transcription.
A termination defect in the absence ofCPSF73 is not un-
expected; however, the effect here is much greater than
previously observed using RNAi (Supplemental Fig.
S1A), and more reminiscent of that observed on some
genes upon cell stress or viral infection (Vilborg et al.
2015; Heinz et al. 2018). It also reveals a broader range of
CPSF73 functions than RNAi depletion, including a role
in transcriptional termination of some long noncoding
RNAs (Supplemental Fig. S1B,C). The extensive nature
of the CPSF73 readthrough also highlights transcriptional
interference in cis. Figure 1F shows an example whereby
readthrough from ERRFL1 reduces the expression of the
convergent PARK7 gene. Finally, CPSF73 depletion did
not affect integrator-dependent snRNA gene termination
demonstrating the specificity of these effects (Supple-
mental Fig. S1D). We conclude that functions of CPSF73
are indispensable for Pol II termination on protein-coding
genes.
Predicted RNA products of XRN2-independent
termination are not abundant
The very long readthrough seen without CPSF73 con-
trasts with our previous measurements of Pol II occupan-
cy in the absence of XRN2 (Eaton et al. 2018). This showed
a more moderate termination defect, defined as such
because readthrough and Pol II signal eventually reduce
to background levels even after XRN2 depletion. To com-
pare XRN2 and CPSF73 effects, we analyzed our
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previously generated nuclear RNA-seq from XRN2-AID
cells and newly generated nuclear RNA-seq from CSF73-
AID cell samples treated or notwith auxin (Fig. 2A).Meta-
gene plotswere generated for all expressed genes separated
from their neighbors by at least 20 kb. Loss of XRN2
shows clear stabilization of readthrough RNA just down-
stream from the PAS as we previously reported (Eaton
et al. 2018), but this effect dissipated by 20 kb. In the ab-
sence of CPSF73, there was also strong stabilization of
readthrough RNA, but this effect was maintained for the
full 20 kb. Thus, there is generally longer readthrough
seen when CPSF73 is depleted versus when XRN2 is
lost. We focused subsequent efforts on establishing the
basis for this difference as a means to understand the ter-
mination mechanism.
A reasonable explanation for this difference is XRN2-
independent termination that still requires CPSF73
(Eaton and West 2018). This mechanism would release
the RNA 3′ end from the terminated polymerase, leaving
it vulnerable to 3′ → 5′ degradation by the exosome, which
degrades many noncoding RNAs shortly after their syn-
thesis (Preker et al. 2008). To test this, we transfected
XRN2-AID cells with control siRNAs or siRNAs to
deplete the exosome (EXOSC3 and EXOSC10) before
treatment or not with auxin to remove XRN2. Chroma-
tin-associated and nucleoplasmic RNA was isolated as
we anticipated that termination products might be re-
leased from chromatin. To check the validity of this ap-
proach, quantitative reverse transcription and PCR
(qRT-PCR) was performed to detect a PROMPT transcript
upstream of RBM39, which is a well-characterized exo-
some substrate. This was strongly stabilized by exosome
depletion, validating siRNA function, with the effect larg-






Figure 1. Acute loss of CPSF73 causes pro-
found transcriptional readthrough. (A) Dia-
gram depicting the strategy for AID tagging
of CPSF73. Homology arms (gray) facilitate
integration of a cassette containing the
AID, separated fromNeomycinorHygromy-
cin resistance genes by a P2A cleavage site
and terminated by an SV40 PAS. Dox-induc-
ible TIR1 is inserted at theAAVS1 locus. (B)
Western blot of parental HCT116:TIR1 cells
andCPSF73-AIDcells thatwereuntreatedor
treated with dox (18 h), auxin (18 h) or dox
(18 h) and then auxin (3 h). The top panel
shows CPSF73 and the bottom panel shows
the tubulin loading control. (C ) Chromo-
somal snapshot from chromatin RNA-seq
of CPSF73-AID cells treated (orange) or not
(blue) with auxin (3 h). Transcription units
are seen in control samples (some examples
shown with dotted lines). Annotated genes
are in blue below the snapshot. Y-axis scale
is transcripts per million (TPM). (D) IGV
snapshots of MAP2K4 and YTHDC2 from
the same experiment shown in C. (E) Meta-
gene plot of expressed genes separated from
their neighbors by at least 100 kb in chroma-
tin RNA-seq of CPSF73-AID cells treated
or not with auxin (3 h). Two biological repli-
cates are plotted. (F ) Example of tran-
scriptional interference induced in cis by
CPSF73 loss where readthrough from
ERRFI1 down-regulates the expression of
PARK7. The right panel shows a zoomed in
version demonstrating reduced PARK7 sig-
nal coincident readthrough from nearby
ERRFI1.
Eaton et al.
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Figure 2. XRN2-independent termination is not readily apparent. (A) Metagene plots of expressed genes separated from their neighbors
by at least 20 kb from nuclear RNA-seq of CPSF73-AID and XRN2-AID cells treated or not with auxin. Note that the n number is lower
here than for the 100-kb window in Figure 1E due to stricter exclusion criteria applied to our previously generated XRN2-AID data (see
SupplementalMaterial). (B) qRT-PCR analysis ofACTB,MYC,RPL30,TRIB1, EIF3E, andEIF3H 3′ flanking RNA in chromatin-associated
and nucleoplasmic RNA fromXRN2-AID cells transfected with control or exosome siRNAs before treatment or not with auxin (2 h). The
graph shows fold change in RNA levels relative to the chromatin fraction of control cells following normalization to spliced ACTB. n=3.
Error bars are SEM. (C ) Schematic illustrating the insertion of xrRNA into the 3′ flank ofMORF4L2 and its predicted effects on transcript
degradation. If there is termination in the absence of 5′ → 3′ degradation this should be revealed by acute DIS3 depletion. CPS is cleavage
and polyadenylation site. (D) qRT-PCR analysis ofMORF4L2 readthrough in unmodifiedDIS3-AID cells andDIS3-AID cells modified at
MORF4L2 by xrRNA insertion, then treated or not with auxin (2 h). The graph shows fold change in RNA at each amplicon relative to
unmodifiedDIS3-AID cells not treatedwith auxin after normalizing to spliced ACTB. n=3. Error bars are SEM. UCPA detects transcripts
not cleaved at the PAS. (E) qRT-PCR analysis ofMORF4L2 readthrough in unmodified XRN2-AID cells and XRN2-AID cells modified at
MORF4L2 by xrRNA insertion, then treated or notwith auxin (2 h). The graph shows fold change in RNAat each amplicon comparedwith
unmodified XRN2-AID cells untreated with auxin after normalizing to spliced ACTB. n =3. Error bars are SEM. (∗) P <0.05 illustrates the
xrRNA effectiveness exemplified at ds600. (F ) Pol II ChIP analysis on unmodified or xrRNA-modifiedMORF4L2 in XRN2-AID cells that
were not subject to treatment. Graph shows relative Pol II IP after normalizing to the ACTB ds1.7 kb amplicon, which is unmodified in
both cell lines. n =3. Error bars are SEM. (∗) P <0.05.
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3′ flanking RNA derived from six protein-coding genes
was then analyzed (Fig. 2B). As expected, all were up-reg-
ulated by loss of XRN2; however, depletion of the
exosome alone had little effect on their levels or distribu-
tion. This argues that their degradation is primarily in the
5′ → 3′ direction. Codepletion of XRN2 and the exosome
did not enhance RNA levels beyond those seen by elimi-
nating XRN2 alone in most cases. MYC and TRIB1 were
two exceptions that showed an additional nucleoplasmic
increase, which may indicate some XRN2-independent
termination on those genes. However, these examples
were still less sensitive to exosome loss than the RBM39
PROMPT control. In our view, these data do not provide
convincing evidence for efficient termination in the ab-
sence of XRN2.
These findings imply that degradation of 3′ flanking
RNA is commonly unidirectional. To probe thismore sen-
sitively,we usedCRISPR–Cas9 to edit theMORF4L2 gene
to include an XRN-resistant RNA (xrRNA). Isolated from
WestNile virus, the xrRNA forms a structure that impairs
5′ → 3′ exonucleases and can be used to probe the direc-
tionality of RNAdecay (Fig. 2C;Chapman et al. 2014;Hor-
vathova et al. 2017). MORF4L2 was chosen because it is
well expressed and, being on the X chromosome, requires
only one editing event to fullymodify. It behaves typically
insofar as its readthrough transcription is longer in the ab-
sence of CPSF73 versus XRN2 (Supplemental Fig. S2B).
We performed this gene editing in our recently described
DIS3-AID cells in which the major catalytic subunit of
the exosome, DIS3, can be rapidly depleted by auxin
(Davidson et al. 2019). Total RNA was isolated from
xrRNA-modified or unmodified DIS3-AID cells treated
or not with auxin and qRT-PCR used to assay the levels
of MORF4L2 RNA upstream of and downstream from
the xrRNA insertion (Fig. 2D). Similar levels of RNA
were obtained upstream of the xrRNA under all condi-
tions; however RNA downstream from the xrRNA was
stabilized consistent with impaired 5′ → 3′ degradation.
This stabilization was not exacerbated by DIS3 loss again
suggesting unidirectional decay and infrequent XRN2-in-
dependent transcriptional termination. Importantly,
DIS3 elimination strongly stabilized other exosome sub-
strates in the same samples (Supplemental Fig. S2C).
An XRN-resistant RNA does not induce profound
readthrough
Another explanation for why readthrough is short in
the absence of XRN2 could be the presence of alternative
5′ → 3′ exonucleases or trace levels of XRN2 remaining af-
ter auxin treatment. To test this, we usedCRISPR–Cas9 to
insert the XRN-resistant RNA (xrRNA) downstream from
MORF4L2 in XRN2-AID cells to inhibit 5′ → 3′ degrada-
tion generally. RNA was isolated from XRN2-AID cells
modified or unmodified atMORF4L2 following treatment
or not with auxin. qRT-PCR analysis of readthrough tran-
scription showed that RNA between the PAS and xrRNA
was stabilized only when XRN2 was depleted as expected
(Fig. 2E). Similar to Figure 2D, RNA downstream from
the xrRNA was stabilized even in the presence of XRN2
demonstrating that the xrRNA inhibits 5′ → 3′ degrada-
tion. Depletion of XRN2 from these cells produced the
expected readthrough but its extent (positions beyond
ds600) was not significantly greater than in unmodified
cells depleted of XRN2. It therefore seems unlikely that
alternative 5′ → 3′ exonucleases generally participate in
termination.
Efficient pursuit of Pol II by XRN2 is important
for termination
The observation that XRN2 initiates degradation at the
PAS but is impeded beyond the xrRNA allows a key
prediction of the torpedo model to be tested: that Pol II
capture, rather than simply degrading RNA, is critical.
Specifically, because the xrRNA impedes degradation
that has already been initiated at the PAS, it should only
result in a termination defect if the continued pursuit of
Pol II is important. We performed Pol II ChIP on
MORF4L2 in xrRNA-modified and unmodified XRN2-
AID cells without depletion of XRN2 (Fig. 2F). The pres-
ence of the xrRNA resulted in significantly enhanced
Pol II occupancy downstream from its position (2.7 kb
and 4.2 kb), strongly suggesting that XRN2 must catch
Pol II (or at least get close to it) to terminate it.
Polymerases accumulate over termination regions in the
absence of XRN2
Data so far show that CPSF73 loss causes runaway read-
through, which is much less extensive when XRN2 is
depleted. This difference is not due to efficient XRN2-
independent mechanisms or other 5′ → 3′ exonucleases,
active when XRN2 is eliminated. We therefore hypothe-
sized that Pol II accumulating beyond the PAS when
XRN2 is eliminated is slowed rather than terminated
and that this is why readthrough is shorter than in the ab-
sence of CPSF73. To interrogate this, we performed Pol II
ChIP on XRN2-AID and CPSF73-AID cells treated or not
with auxin usingMYC andACTB asmodel genes (Fig. 3A).
Auxin was added for 3 h in both cases to eliminate/mini-
mize any effects of different depletion times. Loss of
CPSF73 or XRN2 induces a termination defect on both
genes as expected. The effect of CPSF73 loss was greatest
at positions furthest downstream from the PAS, whereas
the XRN2 effect was more prominent at positions within
2.5 kb of the PAS. This difference is consistent with the
idea that polymerases pile up over termination regions
in the absence of XRN2 but not when CPSF73 is depleted.
This pile up is likely due to slow elongation rather than
complete arrest because 3′ flanking region Pol II can still
incorporate 4-thiouridine in the absence of XRN2 (Supple-
mental Fig. S3A).
We next assayed whether the difference in Pol II behav-
ior caused by XRN2 vs CPSF73 depletion is associated
with any changes in its modification status. The CTD of
the largest Pol II subunit is heavily modified during the
transcription cycle (Eick and Geyer 2013). Thr4p is the
most obvious candidate for CPSF73-dependent modifica-
tion as it predominantly occurs after the PAS and its
Eaton et al.
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position is shifted downstream when CPSF73 is depleted
by RNAi (Schlackow et al. 2017). We assayed Thr4p on
ACTB and MYC in CPSF73-AID and XRN2-AID cells
grown with or without auxin and observed its expected
enrichment beyond the PAS in control samples (Fig. 3B).
XRN2 loss caused an increase in Thr4p signal down-
stream from the PAS for both genes similar to the increase
in total Pol II occupancy observed in Figure 3A; however,
Thr4p is reduced when CPSF73 is eliminated. Thr4p is
therefore downstream fromCPSF73 activity but upstream
of XRN2-dependent transcriptional termination, reveal-
ing a chemical difference between Pol II occupying
3′ flanking regions upon CPSF73 versus XRN2 depletion.
Polymerases accumulate over termination regions in the
absence of XRN2 but transcribe through them when
CPSF73 is eliminated
Reduced Pol II occupancy beyond the PAS is usually inter-
preted as consequential of transcriptional termination.
Our data argue thatXRN2depletion enriches polymerases
that can neither elongate well nor terminate.We designed
an experiment to test thismore directly using a hepatitis δ
ribozyme that cleaves very efficiently and can be inacti-
vated by a single mutation (δRZ[WT/MT]) (Fong et al.
2009). RZ cleavage produces an upstream product that is
degraded from its 3′ end and a downstream product that
cannot be degraded due to a 5′OH (Stevens and Maupin
1987; Muniz et al. 2015). Transcription of the RZ will re-
sult in a stable downstreamproduct, the presence ofwhich
can be used to report instances of transcription beyond its
position. RBM3 was modified with (δRZ[WT/MT]) in
CPSF73-AID andXRN2-AID cells andwas chosen as an al-
ternative toMORF4L2 (it is also X-chromosomal). TheRZ
was inserted just downstream from where termination
normally occurs and loss of XRN2 induces some transcrip-
tion beyond the insertion site (Supplemental Fig. S3B). If,
in the absence of XRN2, the ultimate position of Pol II oc-
cupancy defines an auxiliary termination site, then most
Pol II should transcribe the RZ when XRN2 is depleted.
If instead most Pol II accumulates upstream of the RZ
when XRN2 is eliminated only a fraction will transcribe
beyond it. CPSF73-AID cells act as a control because its
depletion induces profound readthrough beyond the RZ
insertion site (Supplemental Fig. S3B).
qRT-PCR was performed to look at readthrough in
δRZ[WT/MT]-modified CPSF73-AID cells and unmodi-
fied CPSF73-AID cells treated or not with auxin (Fig.
4A). In unmodified cells, CPSF73 loss induced the expect-
ed increase in transcriptional readthrough causing a 25-
fold to 50-fold increase in signal at 8.5 and 11 kb beyond
the RBM3 PAS. The result was similar when RBM3 was
modified with δRZ[MT]. With δRZ[WT], there was again
strong readthrough when CPSF73 was lost. Importantly,
the RZ cleaves in this setting because its upstream prod-
uct does not accumulate when CPSF73 is depleted from
B
A Figure 3. Pol II piles up beyond the PASwhen
XRN2 is depleted. (A) Pol II ChIP analysis on
ACTB and MYC performed in CPSF73-AID
or XRN2-AID cells treated or not with auxin
(3 h). Graph shows relative Pol II IP normalized
to ACTB US/MYC US in each sample. n=3.
Error bars are SEM. (B) Thr4p ChIP analysis
on ACTB and MYC performed in CPSF73-
AID or XRN2-AID cells treated or not with
auxin (3 h). Graph shows relative Thr4p IP nor-
malized ACTB ds1.1 kb and MYC ds1.2 kb in
the respective cell lines not treated with aux-
in. n =3. Error bars are SEM.
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δRZ[WT] samples but shows robust up-regulation in the
presence of δRZ[MT] (see UCPA and 1.1-kb amplicons).
As expected, the 3′ cleavage product cannot be degraded
as its accumulation is similar in δRZ[MT] and δRZ[WT]
scenarios.
In XRN2-AID cells, δRZ[MT]-modification of RMB3
gives a similar result to unmodified XRN2-AID cells in
that XRN2 depletion leads to stabilization of 3′ flanking
region RNA (Fig. 4B). For the δRZ[WT], there is mild up-
regulation of the downstream 8.5-kb amplicon even
when XRN2 is present. This is likely due to a small frac-
tion of Pol II transcribing beyond its position as a similarly
modest stabilization is also seen here in untreated
CPSF73-AID cells modified by δRZ[WT]. Compared
with loss of CPSF73, XRN2 depletion has much less im-
pact on readthrough beyond the δRZ[WT]. This supports
the idea derived from xrRNA-modifiedMORF4L2 that al-
ternate means of 5′ → 3′ degradation do not promote effi-
cient termination when XRN2 is depleted. Finally,
XRN2 depletion also results in stabilization of RNA
upstream of the RZ instead of the destabilization seen
without CPSF73, suggesting that comparatively few poly-
merases go beyond the RZ in its absence. Thus, the fron-
tier of Pol II signal seen when XRN2 is lost is unlikely
to represent an auxiliary termination site and ismore like-
ly to reflect the forefront of polymerases accumulated up-
stream of it. Such accumulation of Pol II beyond the PAS
upon XRN2 depletion is general, based on analysis of our
previously published mNET-seq in cells lacking XRN2
(Supplemental Fig. S3C).
PP1 activity aids termination by XRN2
Recent results in fission yeast implicate PP1 in reducing
elongation rate after the PAS through its dephosphoryla-
tion of SPT5 and Pol II CTD (Kecman et al. 2018; Parua
et al. 2018). We tested whether PP1 activity is involved
in the Pol II slowing first using a small molecule inhibitor
approach. This has possible advantages over protein deple-
tion: It is more acute, may not disrupt PP1-associated
complexes, and is more easily combined with XRN2
depletion to test the relationship between PP1 activity
and torpedo termination in the same cells. We assessed
the impact of PP1 on XRN2-dependent termination using
Pol II ChIP onACTB andMYC in XRN2-AID cells treated
with auxin, the selective PP1 inhibitor, tautomycetin
(Choy et al. 2017), or both (Fig. 5A). XRN2 loss showed
the expected termination defect on both genes character-
ized by an accumulation of Pol II downstream from the
PAS. PP1 inhibition gave a similar Pol II profile to the un-
treated control situation with a slight tendency for more
readthrough transcription. When XRN2 was depleted
from PP1 inhibited cells, the post-PAS accumulation of
Pol II that we had characterized as resulting from
accumulated slow polymerase was reduced. However,
the readthrough at extended positions was maintained.
These observations support the idea that PP1 facilitates
XRN2-dependent termination by promoting Pol II
slowing.
PP1-assisted Pol II slowing might facilitate termination
by expediting the capture of polymerases by XRN2, which
we showed to be an important part of the mechanism in
Figure 2F. To interrogate this, total RNA was isolated
B
A
Figure 4. Pol II piles up over termination regions when XRN2 is
depleted whereas CPSF73 loss induces runaway transcription.
(A) qRT-PCR analysis of RBM3 readthrough in unmodified
CPSF73-AID cells and CPSF73-AID cells modified at RBM3 by
addition of δRZ[WT/MT] and then treated or not with auxin
(3 h). The schematic shows the RZ insertion and predicted impact
on RNA degradation. The graph shows fold change in RNA over
each amplicon relative to unmodified CPSF73-AID cells not
treatedwith auxin after normalising to spliced ACTB. n≥3. Error
bars are SEM. (∗) P <0.05 to highlight significance of smaller fold
effect changes commented on in the main text. UCPA detects
transcripts uncleaved at the PAS. (B) qRT-PCR analysis of
RBM3 readthrough in unmodified XRN2-AID cells and XRN2-
AID cells modified at RBM3 by addition of δRZ[WT/MT] and
then treated or not with auxin (3 h). The graph shows fold change
in RNA at each amplicon relative to unmodified XRN2-AID cells
after normalizing to spliced ACTB. n≥ 3. Error bars are SEM. (∗) P
<0.05 to highlight significance of smaller fold effect changes com-
mented on in the main text.
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from XRN2-AID cells following PP1 inhibition and/or
XRN2 depletion and transcriptional readthrough was as-
sayed for ACTB and MYC by qRT-PCR (Fig. 5B). As ex-
pected, XRN2 loss induced readthrough at both genes.
Tautomycetin also induced transcriptional readthrough,
suggesting that PP1 activity is important for efficient ter-
mination. Treatment with tautomycetin and auxin gave
the biggest effect and was especially strong at positions
furthest beyond the PAS. These effects are larger than in
the above ChIP experiments. This is because ChIP signal
derives from Pol II occupancy of a short fragment of DNA
(due to prior sonication), whereas qRT-PCR signal derives
from intact transcripts and reports everything over and be-
yond a tested amplicon.
Mass spectrometry identified PP1α and β isoforms as
components of the 3′ end processing complex (Shi et al.
2009). We therefore specifically tested their involvement
in transcriptional readthrough using RNAi to deplete ei-
ther or both from XRN2-AID cells (Fig. 5C). We then
used qRT-PCR to assay transcriptional readthrough under
these conditions following treatment or not with auxin to
deplete XRN2 (Fig. 5D). Depletion of PP1 by itself did not
lead to extended readthrough; however, it did so when
XRN2 was subsequently depleted. This was the case for
both MYC and ACTB with the effect more subtle for
the latter. Analysis of another gene (YTFDH3) confirmed
that PP1 depletion enhances readthrough when XRN2 is
eliminated. An additional protein phosphatase inhibitor,
CalyculinA,was used to further confirm the protein phos-
phatase effect on extended ACTB readthrough (Supple-
mental Fig. S4). The combined interpretation of this
ChIP and qRT-PCR is that PP1 is important for Pol II slow-
ing after the PAS and for its efficient capture and termina-
tion by XRN2.
Directed RNaseH1 activity bypasses the requirement
for CPSF73 in transcriptional termination
The importance of XRN2 in transcriptional termination is




Figure 5. PP1 activity underpins the piling
up of Pol II in the absence of XRN2. (A) Pol II
ChIP on ACTB and MYC performed in
XRN2-AID cells that were either untreated
or treated with auxin, tautomycetin or
both (auxin 2 h, tautomycetin 18 h). Graph
shows Pol II IP relative to ACTB US/MYC
US for each sample. n =3. Error bars are
SEM. (B) qRT-PCR analysis of ACTB and
MYC readthrough transcription in XRN2-
AID cells thatwere either untreated or treat-
ed with auxin, tautomycetin, or both (auxin
2 h, tautomycetin 18 h). Graph shows RNA
fold change at each amplicon relative to un-
treated (-aux) cells following normalization
to spliced ACTB. n= 3. Error bars are SEM.
(C ) Western blotting of XRN2-AID cells
treated with control, PP1α, PP1β, or PP1α
and β siRNAs. EXOSC10 is shown as a load-
ing control. mRNA levels (n= 3) are shown
under each blot relative to those in control
siRNA treated cells (shown as 100%) after
normalization to spliced ACTB transcripts.
(D) qRT-PCR analysis of ACTB, MYC, and
YTHDF3 readthrough transcription in
XRN2-AID cells that were treated with con-
trol, PP1α, PP1β, or PP1α and β siRNAs and
then with auxin (2 h) or not. Graph shows
RNA fold change at each amplicon relative
to control siRNA transfected cells not treat-
ed with auxin following normalization to
spliced ACTB. n= 3. Error bars are SEM.
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absence. PP1may also play a direct active role in termina-
tion or it could serve to facilitate the XRN2-dependent
process by slowing Pol II down. Disentangling these possi-
bilities requires experiments to isolate allosteric and tor-
pedo components from one another. To do this we
tested whether alternative endoribonucleolytic cleavage
could support termination on a protein-coding gene fol-
lowing CPSF73 loss, as this would potentially separate
its RNA cleavage and allosteric functions. As the XRN2-
incompatible RZ cleavage does not support termination
in the absence of CPSF73 (Fig. 4A), we used RNaseH1,
which cuts RNA:DNA hybrids and generates substrates
for XRN2 (Hori et al. 2015). To concentrate high levels
of RNaseH1 in the nucleus we integrated it into the ge-
nome after replacing its mitochondrial localization signal
with a nuclear localization signal (to make NLS-RNA-
SEH1). Because the requisite puromycin-resistance mark-
er had been used in CPS73-AID cells (to introduce TIR1),
dox-inducibleNLS-RNASEH1was integrated into our pre-
viously described CPSF73-DHFR cell line (Eaton et al.
2018). In those cells, CPSF73 is depleted by removing tri-
methoprim (TMP) from growth media. The Western blot
in Figure 6A confirms the successful introduction dox-in-
ducible NLS-RNASEH1.
Next, we designed a GapmeR to the last exon of ACTB
close to the PAS. GapmeRs are modified antisense oligo-
nucleotides that, when bound to their target transcript, re-
sult in cleavage by RNaseH1. ACTB or control GapmeRs
were transfected intoNLS-RNASEH1-expressingCPSF73-
DHFR cells.We then added dox in the presence or absence
of TMP to retain or deplete CPSF73. qRT-PCR, using
primers that could only detect uncleaved products, re-
vealed very efficient (>90%) GapmeR-induced cleavage
(Fig. 6B). GapmeR-directed cleavage also suppressed the
strong readthrough caused by CPSF73 depletion as judged
by the reduction in RNA levels beyond the ACTB PAS
(Fig. 6C). This contrasts with the inability of RZ cleavage
to do the same onRBM3 (Fig. 4A), correlating these effects
with the compatibility of cleaved RNAwith 5′ → 3′ degra-
dation. Crucially, Pol II ChIP confirmed that the large ter-
mination defect caused by CPSF73 depletion was almost
completely suppressed by introducing the ACTBGapmeR
(Fig. 6D). This experiment shows that CPSF73 itself is not




Figure 6. Directed RNaseH1 activity pro-
motes transcriptional termination in the ab-
sence of CPSF73. (A) Western blot to detect
NLS-RNaseH1 introduced into CPSF73-
DHFR cells. Its expression is dox-dependent
and CPSF73 is shown as a loading control.
(B) qRT-PCR of NLS-RNASEH1-modified
CPSF73-DHFR cells transfected with con-
trol or ACTB GapmeRs. Primers flanking
the GapmeR targeting site were used to as-
sess cleavage efficiency shown as a fold
change in RNA levels relative to control
GapmeR following normalization to spliced
GAPDH. n= 4. Error bars are SEM. (C ) qRT-
PCR of RNaseH1-modified CPSF73-DHFR
cells transfected with control or ACTB
GapmeR and grown in the presence or ab-
sence of TMP (12 h). Graph shows fold chan-
ge in RNA levels compared with control
GapmeR transfected cells grown in the pres-
ence of TMP (C+CPSF73) following nor-
malization to unspliced ACTB RNA. n=3.
Error bars are SEM. (D) Pol II ChIP of RNa-
seH1-modified CPSF73-DHFR cells trans-
fected with control or ACTB GapmeRs and
grown in the presence or absence of TMP
(12 h).Graph shows relative Pol II IP normal-
ized to Pol II occupancyupstreamof the PAS
(ACTB US) in each condition. n=3. Error
bars are SEM. (E) Thr4p ChIP of RNaseH1-
modified CPSF73-DHFR cells transfected
with control or ACTB GapmeRs. Graph
shows relative Pol II IP normalized to occu-
pancy over the ds1.1-kb amplicon in con-
trol GapmeR transfected cells grown in
TMP (C+CPSF73).n=3. Error bars are SEM.
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part of its normal function in the process is to cleave the
transcript.
As RNaseH1 cleavage of ACTB RNA promotes termi-
nation in the absence of CPSF73, it is likely to do so with-
out associated Pol II slowing. Based on our model, this
means that RNaseH1 cleavage might be relatively faster
than at the ACTB PAS to facilitate Pol II pursuit by
XRN2. To test this assumption, we performed Thr4p
ChIP in RNaseH1-expressing CPSF73-DHFR cells trans-
fectedwith control or ACTBGapmeRs. Because Thr4p de-
pends on CPSF73 (see Fig. 3B), its presence will indicate
prior CPSF73 activity. In control treated cells, Thr4p
was highest at 1.1 and 1.7 kb beyond the PAS as expected
(Fig. 6E). However, Thr4p did not accumulate at those po-
sitions when the ACTB GapmeR was transfected, even
though CPSF73 is still present. This suggests that
GapmeR-directed cleavage is often faster than at the
PAS and provides an explanation for how it promotes effi-
cient termination even in the absence of CPSF73.
RNA cleavage in different locations and by different
RNases promotes transcriptional termination without
CPSF73
NEAT1 and MALAT1 noncoding genes terminate via
CPSF73-independent yet XRN2-dependent mechanisms
(Supplemental Fig. S5), perhaps because their RNAs un-
dergo 3′ end cleavage by RNaseP/Z (Wilusz et al. 2008).
We used CRISPR–Cas9 to insert the 3′ end processing
element from MALAT1 into the 3′ flank of MORF4L2
in CPSF73-AID cells. We performed qRT-PCR to assay
MORF4L2 readthrough in modified and unmodified
CPSF73-AID cells treated or not with auxin (Fig. 7A).
While CPSF73 loss induced very strong readthrough at
the unmodified MORF4L2, this effect was suppressed in
the presence of the MALAT1 3′ end, strongly suggesting
that RNaseP/Z bypasses the need for CPSF73. Interesting-
ly, theMALAT1 3′ end also caused an increase in the level
ofMORF4L2 transcripts that were not cleaved at the PAS,
even when CPSF73 is present. This argues that RNaseP/Z
cleavage often occurs before/without cleavage at the up-
stream PAS similar to GapmeR-directed RNaseH1 at
ACTB. ChIP analysis confirmed that the MALAT1 3′ end
suppresses the effects of CPSF73 loss onMORF4L2 termi-
nation (Fig. 7B). Thus, alternative (and endogenous) RNas-
es can promote termination on protein-coding genes in the
absence of CPSF73.
As these directed RNase experiments occur close to a
PAS, there might be other PAS-dependent features that
promote termination even without CPSF73. To see
whether this is the case, we designed a GapmeR to cleave
the second intron of ETF1 far upstream of its PAS. Impor-
tantly, ETF1 is unlikely to contain cryptic PAS elements
since its transcripts do not undergo premature CPA
when U1 snRNA is inhibited (Kaida et al. 2010). To test
the potential for ETF1 intron cleavage to promote prema-
ture transcriptional termination, we performed qRT-PCR
in NLS-RNASEH1 expressing CPSF73-DHFR cells (with-
out depleting CPSF73) transfected with control or ETF1
GapmeRs (Fig. 7C). We also analyzed equivalent samples
following splicing inhibition using Pladienolide B (PlaB) in
case intron removal confounded pre-mRNA detection. In-
deed, PlaB enhanced all three intron-derived species; how-
ever, this was almost fully suppressed by the ETF1
GapmeR. This included over the cleavage site (showing ef-
ficient cutting) and at downstream position. Pol II ChIP
confirmed that the ETF1 GapmeR induced premature ter-
mination of transcription and did so in the presence and
absence of splicing (Fig. 7D). These experiments indicate
that RNA degradation is, at least in principle, sufficient
for termination, with allosteric features used to facilitate
it in practice. While a PAS-induced modification is not
strictly necessary for transcriptional termination, it is
probably required for the XRN2-dependent process to be
most efficient.
Discussion
We have shown that rapid CPSF73 depletion causes run-
away readthrough, which we propose is because processes
underpinning transcriptional termination are lost. We
identified allosteric and torpedo elements of the transcrip-
tional termination mechanism that were enriched by rap-
id depletion of XRN2. Our experiments reveal the
following mechanism: CPSF73 function (and likely PAS
cleavage) promotes Thr4p with PP1 activity playing an
important role in slowing Pol II down to facilitate its cap-
ture by XRN2. The allosteric eventsmost likely aid XRN2
rather than acting as a separate or mutually exclusive ter-
mination pathway because cleavage of primary tran-
scripts promotes termination in the absence of CPSF73
and outside of a PAS context. Consequently, we propose
that the long-standing allosteric and torpedo models for
transcriptional termination can be unified into a single
mechanism with XRN2 likely providing the termination
activity (Fig. 7E).
This conclusion followed from our failure to detect effi-
cient/general XRN2-independent termination, although
we did observe some evidence for this in two (MYC and
TRIB1) cases. However, 3′-flanking transcripts were al-
ways muchmore sensitive to XRN2 loss than to exosome
depletion and remained largely chromatin-associated un-
der all circumstances. While there may be inefficient or
stochastic XRN2-independent termination, it does not
seem to be linked by a common mechanism. We do not
rule out XRN2-independent termination that evades our
detection or that occurs on certain genes, but our subse-
quent finding that PP1 inhibition causes longer read-
through when XRN2 is depleted argues against efficient
alternatives.
Our results suggest that endoribonucleolytic cleavage
might be an elemental function of CPSF73 in termination.
However, polymerases display runaway readthrough in
the absence of CPSF73 and are not modified by Thr4p,
suggesting that its absence also prevents allosteric events.
There are two broad explanations for this: The first is that
CPSF73 loss prevents the assembly of other 3′ end process-
ing factors that also promote allostery, and the second is
that allosteric events occur downstream from PAS
Transcriptional termination mechanism in humans
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cleavage. While not mutually exclusive, we favor the lat-
ter because of our previous finding that inactive CPSF73
does not support termination (Eaton et al. 2018). Further-
more, PP1 depletion does not affect PAS cleavage (Shi
et al. 2009), but still causes extended transcriptional
readthrough.
Part of themechanism for howPP1 activity causes Pol II
to slowdown is explainedby recentdata from fissionyeast,
in which dephosphorylation of SPT5 occurs specifically
beyond thePAS (Paruaet al. 2018).Consistently, andwhile
we were revising this manuscript, the Bentley lab demon-
strated dephosphorylation of SPT5 beyond the PAS in
human cells associated with XRN2-dependent termina-
tion (Cortazar et al. 2019). Even so, other relevant factors
may be subject to PP1 activity because phosphomimetic
mutations in SPT5 do not lead to termination defects in
fission yeast (Kecman et al. 2018). For instance, p54nrb is
among the many PP1-interacting proteins and promotes
the recruitment of XRN2 to genes (Kaneko et al. 2007; He-
roes et al. 2013). Elucidating the complete network of
phospho-regulation during transcriptional termination is




Figure 7. Other RNases promote termina-
tion in the absence of CPSF73, which can
also occur within gene bodies. (A) qRT-
PCR analysis of MORF4L2 readthrough
in unmodified CPSF73-AID cells and
CPSF73-AID cells modified at MORF4L2
by inserting the MALAT1 3′ end and then
treated or not with auxin (3 h). The graph
shows fold change in RNAat each amplicon
relative to unmodified CPSF73-AID cells
not treated with auxin after normalizing to
spliced ACTB. n =3. Error bars are SEM.
UCPA detects transcripts not cleaved at
the PAS. (B) Pol II ChIP analysis of
MORF4L2 in unmodified CPSF73-AID
cells and CPSF73-AID cells modified at
MORF4L2 by inserting theMALAT1 3′ end
and then treated or not with auxin (3 h).
The graph shows relative Pol II IP normal-
ized to occupancy over MORF4L2 exon 4
in each case. n=3. Error bars are SEM.
(C ) qRT-PCR analysis of ETF1 GapmeR
cleavage effects in RNaseH1-modified
CPSF73-DHFR cells transfected with con-
trol or ETF1 GapmeRs, grown in the pres-
ence of TMP before treatment or not with
PlaB (3 h). The graph shows fold change in
RNA at each amplicon relative to control
GapmeR-treated cells grown without PlaB
after normalizing to splicedACTB. n= 3. Er-
ror bars are SEM.GapmeRcleavage site is il-
lustrated (scissors) in the schematic. (D) Pol
II ChIP of RNaseH1-modified CPSF73-
DHFR cells transfected with control or
ETF1 GapmeRs and grown in the presence
of TMP before treatment or not with PlaB
(3 h). Graph shows relative Pol II IP normal-
ized to occupancy over the GapmeR target
site in each case. n =3. Error bars are SEM.
(E) Model. Normally, Pol II pauses beyond
the PAS in a manner requiring PP1 activity
and associatedwithThr4p,which facilitates
its pursuit and termination by XRN2.
(-CPSF73) Pol II engages in runaway read-
through transcription; (-XRN2) paused Pol
II is paused over 3′ flanking regions unable
to terminate efficiently; (-XRN2 and PP1)
this situation shows extended readthrough
relative to loss ofXRN2alone,which is asso-
ciated with reduced pausing after the PAS;
(RNaseH/P/Zcleavage) bypassesofCPSF73/PAS requirementbypromotingPol II termination inassociationwith5′ → 3′ RNAdegradation.
Filled dots represent phosphates.
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The importance of Pol II slowing for XRN2-dependent
termination likely relates to the respective rates of RNA
transcription and degradation. Pol II elongation rate is on
average ∼2 kb/min with some variation on different genes
(Singh and Padgett 2009; Fuchs et al. 2014). Although the
rate of XRN2 degradation is unknown, the closely related
5′ →3′ exonuclease, XRN1, has recently beenmeasured at
∼2 kb/min (Hoek et al. 2019). Assuming that XRN2 be-
haves similarly, rates of synthesis and degradation are
closely matched. Without pausing, XRN2 may be unable
to catch the polymerase where PAS cleavage is slow or
when Pol II elongation is faster than the average rate. In
support of closelymatching rates, increasing Pol II elonga-
tion rate by only 220 nt/min induces a substantial down-
stream shift of termination positions (Fong et al. 2015).
Finally, the GapmeR and RNase P/Z experiments show
that CPSF73-dependent events can be bypassed by rapid
cleavage. This result also implies that the elemental role
of CPSF73 (and the PAS) in termination is to provide an
end for XRN2, otherwise alternative cleavage would not
function in its absence. It also demonstrates that
CPSF73-dependent changes occurring beyond the PAS fa-
cilitate termination (we propose, by slowing down Pol II)
rather than directly contributing. This is consistent with
the ability for XRN2 to promote termination in vitro in
the absence of other factors (Park et al. 2015). This exper-
iment also has additional implications for the study of
noncoding RNA function, which often relies on the as-
sumption that their targeting by antisense oligonucleo-
tides does not affect transcription of their locus. We
suggest that premature transcriptional terminationmight
also occur in some of these experiments.
Materials and methods
Cell culture and transfections
HCT116 cells were cultured in DMEM (high glucose) containing
penicillin/streptomycin and 10% FBS at 37°C. DNA transfec-
tions were done with Jetprime (polyplus) and RNAi with Lipo-
fectamine RNAiMAX (Life Technologies) following the
manufacturers’ guidelines. Two siRNA transfections were used:
the second 24 h after the first and RNA isolation 48 h after
that. PP1 RNAi was performed using a single siRNA transfection
with RNA isolated 72 h later. GapmeRs were transfected at 10
nM in 24-well or 100-mm dishes for RNA and ChIP experiments,
respectively. This was done using 1.5 or 10 μL of Lipofectamine
RNAiMAX in a final combined volume of 50 or 500 μL of Opti-
MEM (Life Technologies). Dox was used at 1 μg/mL, auxin was
used at 500 μM, tautomycetin was used at 500 nM, PlaB was
used at 1 nM, and calyculin A was used at 5 nM. TMP was used
at 20 µM and withdrawn for 12 h to deplete CPSF73-DHFR.
Cell lines and cloning
The XRN2-AID and CPSF73-eDHFR cell lines are previously de-
scribed (Eaton et al. 2018).NLS-RNASEH1was synthesized by In-
tegrated DNA Technologies and cloned into pMK243 (Addgene
72835) digestedwithMluI and BglII. This plasmidwas transfected
with AAVS1 T2 CRISPR plasmid (Addgene 72833), and colonies
were selected in 1 μg/mL puromycin. The CPSF73-AID cell line
was made by generating plasmids containing a 5′ homology arm
– AID – P2A – HYG/NEO – SV40 PAS – 3′ homology arm. We
have published the sequences of each of these elements (Eaton
et al. 2018). These, togetherwith px330 (Addgene 42230) contain-
ing a CPSF73 guide RNA sequence, were transfected into
HCT116 cells containing dox-inducible TIR1 and colonies select-
ed with 30 μg/mL hygromycin and 800 μg/mL neomycin.
HCT116 cells containing inducible TIR1weremade by transfect-
ing HCT116 cells with pMK243 and AAVS1 T2 CRISPR plasmid,
followed by selection in 1 μg/mL Puromycin. The RBM3 and
MORF4L2 gene insertions weremade using coselection (Agudelo
et al. 2017). gRNA sequences were cloned into Addgene plasmid
86611 and transfected with a plasmid containing insertion ele-
ments (see the Supplemental Material) flanked with homology
arms. Positive clones were selected by growth in 0.5 μMouabain.
Insertions were confirmed by Sanger sequencing.
Antibodies
The following antibodies were used: CPSF73 (Bethyl Laboratories
A301-090A), Tubulin (Abcam Ab7921), HA (Roche 3F10), Thr4p
(Active Motif 6D7), EXOSC10 (Santa Cruz Biotechnology Sc-
374595-X), PP1α (Bethyl Laboratories A300-904A), PP1β (Bethyl
Laboratories A300-905A), and RNA Pol II (MBL Technologies
CMA601 andAbcam8WG16).Note thatCMA601was discontin-
ued during our study and used in Figures 3A and 6D.
Total RNA isolation and qRT-PCR
RNA was isolated using tri-reagent and, following DNase treat-
ment, 1 μg was reverse transcribed (Protoscript II, New England
Biolabs) with random hexamers. cDNA was diluted to 50 μL in
water and 1 μL was used per qPCR, performed with LUNA
qPCR reagent (New England Biolabs) in a Qiagen Rotorgene
instrument.
Chromatin-associated and nucleoplasmic RNA isolation
A six-well dish of cells was lysed in in HLB (10 mM Tris pH 7.5,
10mMNaCl, 2.5mMMgCl2, 0.5%NP40); this was underlayered
withHLB+10%sucrose and spun at 500×g for 5min.Nucleiwere
resuspended in 100 μL of NUN1 buffer (20 mM Tris.HCl pH 7.9,
75 mM NaCl, 0.5 mM EDTA, 50% glycerol, 0.85 mM DTT) and
then topped upwith 1mL ofNUN2 (20mMHEPES pH 7.6, 1mM
DTT, 7.5 mMMgCl2, 0.2 mM EDTA. 0.3 M NaCl, 1 M urea, 1%
NP40). After incubation for 10 min on ice with mixing every 2–
3 min, samples were spun at 13,000 rpm for 10 min. Chromatin
pellets were resuspended in 500 μL of Tri-reagent and RNA
was isolated with Trizol as above. Nucleoplsamic RNA was ex-
tracted from the supernatant by phenol chloroform and ethanol
precipitation.
RNA sequencing
For chromatin-associated RNA-seq, cells were treated with dox/
EtOH (18 h) and then with auxin/EtOH (3 h). Nuclear RNA-seq
was performed following treatment with dox (18 h) and then aux-
in/EtOH (3 h). Five-hundred nanogramswas rRNAdepleted using
the Ribozero kit, and libraries were prepared with the tru-seq
stranded kit and sequenced on an illumina Hi-seq 2500. Data pro-
cessing steps are described in the Supplemental Material.
Chromatin immunoprecipitation
A semi-confluent 100-mm dish of cells was cross-linked in 1%
fomaldehyde for 10 min before quenching in 125 mM glycine.
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Cells were pelleted and resuspended in 350 μL RIPA buffer (150
mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS,
50 mM Tris.HCl pH 8, 5 mM EDTA pH 8) before sonication in
a Bioruptor for 30 sec on and 30 sec off 10 times on high. Cross-
linked chromatin was divided into two: Half was incubated
with 40 μL of sheep antimouse/sheep antirat Dynabeads (Life
Technologies) preincubated with 3 μg of Pol II/Thr4p antibody
for 2 h at 4°C, and the other half with beads incubatedwithout an-
tibody. Following rotation for 3 h at 4°C, beadswerewashed twice
in RIPA buffer, three times in ChIP wash buffer (500 mM NaCl,
1% NP40, 1% sodium deoxycholate, 100 mM Tris.HCl pH 8.5),
and twice in RIPA buffer (ChIP wash washes were not used for
Thr4p). DNA was eluted in 0.1 M NaHCO3/1% SDS with rota-
tion for 30 min at room temperature. Eluate was added to 30 μL
of 5 M NaCl and cross-links were reversed overnight at 70°C.
DNA was purified by phenol chloroform extraction and ethanol
precipitation and resuspended in 50 μL of water. One microliter
was used per qPCR.
Gene expression omnibus accession numbers
RNA-seq and mNET-seq of XRN2-AID cells (GSE109003); chro-
matin and nuclear RNA-seq of CPSF73-AID cells (GSE137727);
CPSF73 RNAi chromatin RNA-seq (GSE60358).
DNA sequences
All DNA sequences are provided in the Supplemental Material.
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